OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PETKM59

Petkim Petrokimya Holding AS

Commodity ChemicalsVerified

Petkim's capital structure is highly leveraged, with a debt-to-equity ratio of 0.8, indicating a moderate reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.56 and negative free cash flow of -9.54 billion TRY. The negative operating cash flow of -8.58 billion TRY further signals operational strain, with the company unable to generate sufficient cash from its core activities to service its obligations. Profitability metrics are deeply negative, with a return on equity of -16% and a return on assets of -6.76%. These figures are well below the typical performance of firms in the Commodity Chemicals industry, which is characterized by thin margins and cyclical demand. The company's gross profit of -3.08 billion TRY and operating loss of -13.10 billion TRY highlight the severity of its underperformance. Geographically, Petkim is heavily concentrated in Turkey, with the majority of its revenue derived from domestic operations. The company has no disclosed international revenue segments, which increases its exposure to local economic and regulatory risks. This lack of diversification is a concern, especially given the volatility of the Turkish economy and the sector's sensitivity to raw material prices. The company's growth trajectory is negative, with no clear signs of recovery in the near term. Analysts have assigned a mean price target of 14.97 TRY, but the absence of strong-buy or buy ratings suggests a lack of confidence in the stock's upside potential. The mean recommendation of 3.33 (on a 1-5 scale) reflects a cautious outlook, with four "hold" ratings and no positive recommendations. Risk factors are elevated, with a medium liquidity risk and a negative cash flow position. The company's long-term debt of 51.42 billion TRY is significantly higher than its cash and equivalents of 4.23 billion TRY, leaving it vulnerable to refinancing risks. The risk assessment also flags the negative net cash position after subtracting total debt as a key concern. While dilution risk is currently low, the company's financial distress could lead to equity issuance in the future, which would dilute existing shareholders. Recent filings and transcripts indicate that Petkim is grappling with declining demand and rising input costs, particularly in energy and feedstock. The company has not disclosed any major strategic initiatives or cost-cutting measures in its latest reports, which raises concerns about its ability to restore profitability. The absence of a clear turnaround plan further exacerbates the uncertainty surrounding its future performance.

30-day price · PETKM+2.42 (+11.6%)
Low$20.12High$28.06Close$23.22As of22 May, 00:00 UTC
Profile
CompanyPetkim Petrokimya Holding AS
TickerPETKM.IS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Petkim Petrokimya Holding AS is a Turkish chemicals company that produces and distributes a range of commodity chemicals, primarily serving the plastics, textiles, and construction industries.

Classification. Petkim is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Petkim's capital structure is highly leveraged, with a debt-to-equity ratio of 0.8, indicating a moderate reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.56 and negative free cash flow of -9.54 billion TRY. The negative operating cash flow of -8.58 billion TRY further signals operational strain, with the company unable to generate sufficient cash from its core activities to service its obligations. Profitability metrics are deeply negative, with a return on equity of -16% and a return on assets of -6.76%. These figures are well below the typical performance of firms in the Commodity Chemicals industry, which is characterized by thin margins and cyclical demand. The company's gross profit of -3.08 billion TRY and operating loss of -13.10 billion TRY highlight the severity of its underperformance. Geographically, Petkim is heavily concentrated in Turkey, with the majority of its revenue derived from domestic operations. The company has no disclosed international revenue segments, which increases its exposure to local economic and regulatory risks. This lack of diversification is a concern, especially given the volatility of the Turkish economy and the sector's sensitivity to raw material prices. The company's growth trajectory is negative, with no clear signs of recovery in the near term. Analysts have assigned a mean price target of 14.97 TRY, but the absence of strong-buy or buy ratings suggests a lack of confidence in the stock's upside potential. The mean recommendation of 3.33 (on a 1-5 scale) reflects a cautious outlook, with four "hold" ratings and no positive recommendations. Risk factors are elevated, with a medium liquidity risk and a negative cash flow position. The company's long-term debt of 51.42 billion TRY is significantly higher than its cash and equivalents of 4.23 billion TRY, leaving it vulnerable to refinancing risks. The risk assessment also flags the negative net cash position after subtracting total debt as a key concern. While dilution risk is currently low, the company's financial distress could lead to equity issuance in the future, which would dilute existing shareholders. Recent filings and transcripts indicate that Petkim is grappling with declining demand and rising input costs, particularly in energy and feedstock. The company has not disclosed any major strategic initiatives or cost-cutting measures in its latest reports, which raises concerns about its ability to restore profitability. The absence of a clear turnaround plan further exacerbates the uncertainty surrounding its future performance.
Key takeaways
  • Petkim is experiencing severe financial distress, with negative operating and net income, and a weak liquidity position.
  • The company's profitability metrics are among the worst in the Commodity Chemicals industry, with a return on equity of -16%.
  • Petkim's geographic concentration in Turkey increases its exposure to local economic and regulatory risks.
  • Analysts have assigned a neutral to cautious outlook, with no strong-buy or buy ratings and a mean price target of 14.97 TRY.
  • The company's high debt load and negative cash flow position pose significant liquidity and refinancing risks.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTRY
Revenue$89.08B
Gross profit-$3.08B
Operating income-$13.10B
Net income-$10.23B
R&D
SG&A
D&A
SBC
Operating cash flow-$8.58B
CapEx-$5.18B
Free cash flow-$9.54B
Total assets$151.33B
Total liabilities$87.37B
Total equity$63.96B
Cash & equivalents$4.23B
Long-term debt$51.42B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$63.96B
Net cash-$47.18B
Current ratio0.6
Debt/Equity0.8
ROA-6.8%
ROE-16.0%
Cash conversion84.0%
CapEx/Revenue-5.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricPETKMActivity
Op margin-14.7%5.5% medp25 -0.0% · p75 10.8%bottom quartile
Net margin-11.5%4.1% medp25 0.1% · p75 8.8%bottom quartile
Gross margin-3.5%20.5% medp25 12.4% · p75 29.7%bottom quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-5.8%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity80.0%37.1% medp25 10.3% · p75 82.0%above median
Observations
IR observations
Mean price target14.97 TRY
Median price target13.80 TRY
High price target20.10 TRY
Low price target10.00 TRY
Mean recommendation3.33 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count4.00
Sell count2.00
Strong-sell count0.00
Mean EPS estimate-0.42 TRY
Last actual EPS-4.04 TRY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-23 00:23 UTC#25469a28
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 23:07 UTCJob: ff4c1923